Newborn Screening Market Size, Share & Trends Report

Newborn Screening Market Size, Share & Trends Analysis Report By Technology (Tandem Mass Spectrometry, Pulse Oximetry), By Type of Test (Dry Blood Spot Test, CCHD), And Segment Forecasts, 2012 - 2022

Report ID: 978-1-68038-490-1
Number of Pages: 95
Format: Electronic (PDF)

Historical Range: 2012 - 2015
Industry: Healthcare

Market segmentation

Global Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
- Instruments
- Reagents & Assay Kits
Global Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
- Tandem Mass Spectrometry
- Pulse Oximetry
- Enzyme Based Assays
- DNA Assays
- Electrophoresis
Global Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
- Dry Blood Spot Test
- Critical Congenital Heart Disease (CCHD)
- Hearing Screen
Newborn Screening Regional Outlook (Revenue, USD Million, 2012 - 2022)
- North America
  - The U.S.
    - The U.S. Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
      - Instruments
      - Reagents & Assay Kits
- Europe
  - The U.K.
    - The U.K. Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
      - Instruments
      - Reagents & Assay Kits
    - The U.K. Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
    - The U.K. Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Germany
    - Germany Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
      - Instruments
      - Reagents & Assay Kits
    - Germany Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
    - Germany Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - France
    - France Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
      - Instruments
      - Reagents & Assay Kits
    - France Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
    - France Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
- Asia Pacific
  - Japan
    - Japan Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
      - Instruments
      - Reagents & Assay Kits
    - Japan Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
    - Japan Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - China
    - China Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
      - Instruments
      - Reagents & Assay Kits
    - China Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
    - China Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - India
    - India Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
      - Instruments
      - Reagents & Assay Kits
    - India Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
    - India Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
- Latin America
  - Brazil
    - Brazil Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
      - Instruments
      - Reagents & Assay Kits
    - Brazil Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
    - Brazil Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
  - Mexico
    - Mexico Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
      - Instruments
      - Reagents & Assay Kits
    - Mexico Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
    - Mexico Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen
- MEA
  - South Africa
    - South Africa Newborn Screening Product Outlook (Revenue, USD Million, 2012 - 2022)
      - Instruments
      - Reagents & Assay Kits
    - South Africa Newborn Screening Technology Outlook (Revenue, USD Million, 2012 - 2022)
      - Tandem Mass Spectrometry
      - Pulse Oximetry
      - Enzyme Based Assays
      - DNA Assays
      - Electrophoresis
    - South Africa Newborn Screening Test Outlook (Revenue, USD Million, 2012 - 2022)
      - Dry Blood Spot Test
      - Critical Congenital Heart Disease (CCHD)
      - Hearing Screen

Report Content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2012 to 2022
Revenue estimates for product up to 2022
Regional market size and forecast for product up to 2022
Revenue estimates for technology up to 2022
Regional market size and forecast for technology up to 2022
Revenue estimates for test up to 2022
Regional market size and forecast for test up to 2022
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.